multiple myeloma, elderly frail patients, dexamethasone-sparing strategy
Teclistamab, Therapy management, Relapsed and refractory multiple myeloma, Expert recommendations, Bispecific antibody, Special patient populations
Multiple myeloma, real-world data, therapeutic management
Multiple Myeloma, Anti-BCMA Bispecific Antibodies, hypogammaglobulinemia, infections